Cannabidiol, a novel inverse agonist for GPR12. 21 Sep Dr D Antitumorigenic targets of cannabinoids – current status and implications. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.